Sinopharm Group CoSHTDF -2.67%78 OCF Yield % is 32.57 as of Jun. 25, 2026, which is 58% above its 10-year median of 20.60. GuruFocus rates SHTDF with a GF Score™ of 78/100 and a GF Value™ of $3.03 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 119 Medical Distribution companies, Sinopharm Group Co ranks better than 91.6% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Sinopharm Group Co OCF Yield % Related Terms
Sinopharm Group Co OCF Yield % Historical Data
* Premium members only.
The historical data trend for Sinopharm Group Co's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Sinopharm Group Co's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sinopharm Group Co OCF Yield % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Sinopharm Group Co's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Sinopharm Group Co's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sinopharm Group Co (SHTDF) has a OCF Yield % of 32.57 as of Jun. 25, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Sinopharm Group Co and its competitors. This is 58% above median its historical median of 20.60. Over the past decade, Sinopharm Group Co's OCF Yield % has ranged from 2.94 to 44.05. According to the industry distribution chart, Sinopharm Group Co ranks #10 out of 119 companies in the Medical Distribution industry, placing it in the top 8.4%.
Is Sinopharm Group Co's OCF Yield % too high?
Sinopharm Group Co's current OCF Yield % of 32.57 is 58% above median its 10-year median of 20.60. Over the past 10 years, this metric has ranged from a low of 2.94 to a high of 44.05. The Medical Distribution industry median OCF Yield % is 5.98. Sinopharm Group Co's value of 32.57 is 444.6% above this industry median. Based on the distribution chart, Sinopharm Group Co ranks #10 out of 119 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Sinopharm Group Co has a GF Score™ of 78/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sinopharm Group Co's OCF Yield % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Sinopharm Group Co ranks #10 out of 119 companies for OCF Yield %. This places Sinopharm Group Co in the top 8% of its industry — outperforming the majority of peers. The industry median OCF Yield % is 5.98. Sinopharm Group Co's value of 32.57 is 444.6% above this benchmark. Historically, Sinopharm Group Co's own OCF Yield % has ranged from 2.94 to 44.05 over the past decade. While the company's 10-year median is 20.60 vs. the industry median of 5.98, Sinopharm Group Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Medical Distribution company?
The median OCF Yield % among Medical Distribution companies is 5.98, based on 119 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sinopharm Group Co's current OCF Yield % of 32.57 is 444.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Sinopharm Group Co and its competitors. For the Medical Distribution industry, the median OCF Yield % is 5.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sinopharm Group Co's current OCF Yield % is 32.57, which is 58% above median its own 10-year median of 20.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sinopharm Group Co stock overvalued right now?
Based on GuruFocus' analysis, Sinopharm Group Co (SHTDF) is currently considered Modestly Undervalued. The stock's GF Value™ is $3.03, compared to a current price of $2.29 — trading 24.5% below its estimated fair value. The current OCF Yield % is 32.57, which is 58% above median its 10-year median of 20.60 and 444.6% above the Medical Distribution industry median of 5.98. Sinopharm Group Co's overall GF Score™ is 78/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Sinopharm Group Co (SHTDF), the current OCF Yield % is 32.57 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sinopharm Group Co (SHTDF) Overvalued in 2026?
Based on GuruFocus' analysis, Sinopharm Group Co stock appears to be undervalued.
The current stock price of $2.29 is trading 24.5% below its estimated GF Value™ of $3.03.
GuruFocus considers Sinopharm Group Co to be Modestly Undervalued.
Key valuation signals for SHTDF:
OCF Yield %: 32.57 (58% above median its 10-year median of 20.60)
GF Value™: $3.03 vs. price of $2.29 (24.5% below fair value)
Industry Position: 444.6% above the Medical Distribution median (#10 of 119)
No single metric tells the full story. See the SHTDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Founded in 2003, Sinopharm is the largest wholesaler and retailer of drugs and medical devices in China and listed on the Hong Kong Stock Exchange in 2009. It is a core subsidiary of China National Pharmaceutical Group. Sinopharm's largest operating segment is pharmaceutical distribution, making up over 70% of its total revenue by the end of 2024. In 2018, Sinopharm acquired the largest Chinese medical device distributor, China National Scientific Instruments and Materials. Now, medical device distribution accounts for over 20% of Sinopharm's total revenue. Sinopharm's downstream customers range from hospitals and other health services institutions to end-customers.
78GF Score
Get the complete analysis for SHTDF
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHTDF has been successfully added to your 
